BioCentury
ARTICLE | Company News

Cancer Genetics sales and marketing update

November 25, 2013 8:00 AM UTC

Cancer Genetics launched its fluorescence in situ hybridization (FISH)-based HPV-Associated Cancer Test (FHACT) to identify women with high risk of progressing to cervical cancer. The laboratory-devel...